Donanemab in Early Symptomatic Alzheimer’s Disease: Efficacy and Safety in TRAILBLAZER-ALZ 2, a Phase 3 Randomized Clinical Trial Abstract ID 1978 Donanemab in Early Symptomatic Alzheimer’s Disease: Efficacy and Safety in TRAILBLAZER-ALZ 2, a Phase 3 Randomized Clinical Trial
Cerebrovascular disease in a cohort of geriatrics patients with COVID-19 in a South American hospital Abstract ID 2070 Cerebrovascular disease in a cohort of geriatrics patients with COVID-19 in a South American hospital
Melatonin modestly improves sleep efficiency in patients with neurocognitive disorders: a systematic review and meta-analysis Abstract ID 1625 Melatonin modestly improves sleep efficiency in patients with neurocognitive disorders: a systematic review and meta-analysis
'Frailty as an adjective rather than a diagnosis' - The Identification of Frailty in Primary Care: a qualitative interview study Abstract ID 1363 'Frailty as an adjective rather than a diagnosis' - The Identification of Frailty in Primary Care: a qualitative interview study
Remote healthcare monitoring systems following traumatic brain injury in older adults: A descriptive case analysis Abstract ID 1415 Remote healthcare monitoring systems following traumatic brain injury in older adults: A descriptive case analysis
Anticholinergic prescribing habits and its associations in a community population of people living with dementia. Abstract ID 1362 Anticholinergic prescribing habits and its associations in a community population of people living with dementia.
Morpho-functional evaluation of 3mg/kg ICV-STZ rat showed sporadic Alzheimer's like pathology with progressive dementia Abstract ID 1147 Morpho-functional evaluation of 3mg/kg ICV-STZ rat showed sporadic Alzheimer's like pathology with progressive dementia
Grey matter volume and neurotransmitter receptors abnormalities in Parkinson’s Disease Psychosis: A meta-analysis Abstract ID 1218 Grey matter volume and neurotransmitter receptors abnormalities in Parkinson’s Disease Psychosis: A meta-analysis